|
|
||||||||
Rochester, New York
ABSTRACT
A method, based on radioactivity measurements, is described for determining total iodine in highly radioactive iodide samples. In 131I-labeling of protein or other substances, by procedures in which 131I as iodide is oxidized to positive iodine, this analysis permits calculation of the amount of iodine incorporated in the labeled product. When the iodinating agent is iodine monochloride, into which 131I is introduced by isotopic exchange, this analysis makes it possible to predict the fraction of the 131I used that will be in the iodinated substance.
FOOTNOTES
1 From the Department of Radiation Biology, University of Rochester School of Medicine and Dentistry, Rochester, New York.
2 This paper is based on work performed under contract with the U. S. Atomic Energy Commission at the University of Rochester Atomic Energy Project, Rochester, New York.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |